Sleep Apnea And UARS: Root Causes Beyond The CPAP Machine

Sleep-disordered breathing is one of the most underdiagnosed drivers of fatigue, brain fog, and autonomic dysfunction in chronically ill patients.

In this post, we will discuss the difference between obstructive sleep apnea, central sleep apnea, and upper airway resistance syndrome, what causes airway collapse at the mechanistic level, how it overlaps with POTS and dysautonomia, and what treatment options exist beyond the CPAP machine.

---

What Is Sleep-Disordered Breathing

Sleep-disordered breathing is an umbrella term for conditions that disrupt normal breathing during sleep. R

It ranges from benign snoring to life-threatening apnea and includes obstructive sleep apnea, central sleep apnea, and upper airway resistance syndrome. R

The unifying feature is that fragmented breathing leads to sleep fragmentation, sympathetic activation, and downstream cardiovascular, metabolic, and neurological consequences. R

Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is characterized by repetitive complete or partial collapse of the upper airway during sleep, despite ongoing respiratory effort. R

Each obstructive event causes a drop in oxygen, a surge in sympathetic nervous system activity, and a brief arousal from sleep. R

Over time this pattern contributes to hypertension, arrhythmia, insulin resistance, depression, and cognitive impairment. R

Risk factors include obesity, male sex, age, craniofacial anatomy, and nasal obstruction. R

Central Sleep Apnea

Central sleep apnea (CSA) occurs when the brain fails to generate a respiratory signal, so there is no effort to breathe. R

It is often associated with unstable ventilatory control, heart failure, opioid use, or high-altitude exposure. R

Unlike OSA, the airway is open, but the diaphragm does not receive the command to move. R

CSA requires different treatment than OSA and often needs specialist management.

Upper Airway Resistance Syndrome

Upper airway resistance syndrome (UARS) is an intermediate condition on the sleep-disordered breathing spectrum. R

It features increased resistance in the upper airway that causes frequent micro-arousals called respiratory effort-related arousals (RERAs), but it typically lacks the oxygen desaturation seen in OSA. R

Patients with UARS often report unrefreshing sleep, daytime fatigue, brain fog, and somatic symptoms, yet their home sleep apnea test may come back "normal." R

This makes UARS one of the most commonly missed diagnoses in the chronic fatigue and dysautonomia population.

Root Causes And Anatomy

The upper airway is a collapsible tube surrounded by soft tissue and supported by bony structures. R

Anything that narrows the airway or reduces the muscle tone that holds it open increases the risk of collapse during sleep. R

Anatomical Contributors

Craniofacial narrowing. A small or recessed jaw, narrow palate, or elongated face reduces airway volume. R Nasal obstruction. A deviated septum, enlarged turbinates, or nasal valve collapse increases inspiratory resistance. R Tongue position. A low tongue resting posture or tongue tie can allow the tongue to fall back during sleep. R Soft tissue enlargement. Tonsillar hypertrophy, fatty infiltration, or inflammation can narrow the airway. R Obesity. Excess fat deposition around the neck and airway increases external pressure on the pharyngeal airway. R

Neuromuscular Contributors

Reduced pharyngeal muscle tone during sleep. Sleep normally reduces muscle tone, but in susceptible individuals this reduction is excessive. R High loop gain. Some people have an exaggerated ventilatory response to small changes in CO2, leading to unstable breathing patterns. R Low arousal threshold. A low threshold means the brain wakes up too easily in response to minor airway resistance, causing fragmented sleep. R

Overlap With POTS And Dysautonomia

There is a significant overlap between sleep-disordered breathing and autonomic dysfunction. R

Each apneic or resistive event triggers a sympathetic surge, releasing catecholamines and raising heart rate and blood pressure. R

In people with POTS or dysautonomia, this nocturnal sympathetic overload can worsen daytime orthostatic intolerance, tachycardia, and fatigue. R

Jacob's hypothesis is that sleep-disordered breathing amplifies the vascular and autonomic stress seen in junction dysfunction, particularly in those with vascular POTS or capillary leak patterns.

Treating the airway can sometimes reduce the need for as many medications aimed at the autonomic nervous system.

Diagnosis

The gold standard for diagnosing sleep-disordered breathing is in-laboratory polysomnography (PSG). R

PSG includes EEG to confirm sleep stages, plus sensors for airflow, respiratory effort, oxygen saturation, and leg movements. R

Home sleep apnea testing (HSAT) is more convenient but has important limitations. R

HSAT typically lacks EEG and esophageal pressure monitoring, so it often misses UARS and mild OSA. R

If you suspect UARS but your HSAT was normal, a full PSG may be necessary.

Treatment Options

CPAP

Continuous positive airway pressure (CPAP) is the first-line treatment for moderate-to-severe OSA. R

It works by delivering a constant stream of air that pneumatically splints the airway open. R

CPAP is highly effective when tolerated, but adherence is a major issue for many patients. R

Oral Appliances

Mandibular advancement devices move the lower jaw and tongue forward, increasing airway space. R

They are often used for mild-to-moderate OSA or for people who cannot tolerate CPAP. R

A dentist trained in dental sleep medicine should fit these devices.

Myofunctional Therapy

Myofunctional therapy consists of exercises that strengthen the tongue, soft palate, and oropharyngeal muscles. R

A meta-analysis found that myofunctional therapy reduced apnea-hypopnea index by approximately 50% in adults and 62% in children. R

It is often used alongside other treatments rather than as a standalone cure.

Positional Therapy

Some people have airway collapse primarily when sleeping on their back. R

Positional therapy uses devices or strategies to keep the person sleeping on their side.

It works best when OSA is strongly position-dependent.

Weight Management

For people with obesity-related OSA, weight loss can significantly reduce severity. R

Even modest weight loss can reduce AHI and improve symptoms.

Nasal And Surgical Options

Nasal steroids or surgery for chronic nasal obstruction can reduce airway resistance. R Tongue tie release may help selected cases with restricted tongue mobility, though evidence as a standalone treatment for OSA in adults is still developing. R Maxillomandibular advancement surgery is reserved for severe cases with clear anatomical narrowing. R

Mechanisms Of Action

Simple:

The upper airway is a muscular tube that relaxes during sleep. If it narrows too much, airflow becomes turbulent or blocked. The brain briefly wakes up to reopen the airway, fragmenting sleep and activating the stress response.

Advanced:

Upper airway collapsibility. The pharyngeal airway is kept open by a balance of structural support and neuromuscular tone. During sleep, reduced tone plus anatomical narrowing raises the critical closing pressure, making collapse more likely. R Loop gain instability. High loop gain means a small rise in CO2 triggers an exaggerated ventilatory response, which overshoots and destabilizes breathing control. R Arousal threshold. A low arousal threshold causes the brain to wake before compensatory mechanisms can resolve the airway event, leading to fragmented sleep. R Sympathetic activation. Each arousal triggers catecholamine release, causing surges in heart rate and blood pressure that repeat throughout the night. R

Genetics

HLA-DQB1

HLA-DQB1 has been associated with obstructive sleep apnea susceptibility in some populations. R

Variants may influence immune-related airway inflammation. R

ADRB2

ADRB2 encodes the beta-2 adrenergic receptor, which influences airway tone and autonomic responses during sleep. R

Variants may affect upper airway collapsibility and response to therapy. R

TNF

TNF encodes tumor necrosis factor alpha, a pro-inflammatory cytokine. R

Elevated TNF-alpha is associated with sleep-disordered breathing and daytime sleepiness. R

More Research

Cardiovascular risk. OSA is independently associated with hypertension, atrial fibrillation, heart failure, and stroke, even after adjusting for other risk factors. R Cognitive effects. Repeated nocturnal hypoxia and sleep fragmentation are linked to memory impairment, executive dysfunction, and increased dementia risk. R Metabolic effects. OSA is associated with insulin resistance and non-alcoholic fatty liver disease, partly through sympathetic and hypoxic mechanisms. R Testing. For biomarker testing I use the Comprehensive Sleep Panel and Hormone Panel to assess cortisol rhythm, melatonin, and other sleep-related biomarkers.